[1] WESTHOFF C M.AMIS and antigen modulation:of mice and men[J].Blood,2016,128(26):3026-3028.
[2] YU H H,STOWELL S R,BERNARDO L,et al.Antibody -mediated immune suppression of erythrocyte alloimmunization can occur independently from red cell clearance or epitope masking in a murine model[J].J Immunol,2014,193(6):2902-2910.
[3] KUMPEL B M.On the immunologic basis of Rh immune globulin (anti-D) prophylaxis[J].Transfusion,2006,46(9):1652-1656.
[4] GETAHUN A,HEYMAN B.Studies on the mechanism by which antigen-specific IgG suppresses primary antibody responses:evidence for epitope masking and decreased localization of antigen in the spleen[J].Scand J Immunol,2009,70(3):277-287.
[5] BERGSTRÖM J J E,XU H,HEYMAN B.Epitope-specific suppression of IgG responses by passively administered specific IgG:evidence of epitope masking[J].Front Immunol,2017,8:238.DOI:10.3389/fimmu.2017.00238.
[6] HJELM F,CARLSSON F,GETAHUN A,et al.Antibody-mediated regulation of the immune response[J].Scand J Immunol,2006,64(3):177-184.
[7] KUMPEL B M.Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn[J].Clin Exp Immunol,2008,154(1):1-5.
[8] SONNEVELD M E,KOELEWIJN J,DE HAAS M,et al.Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn[J].Br J Haematol,2017,176(4):651-660.
[9] BRANCH D R,SHABANI F,LUND N,et al.Antenatal administration of Rh-immune globulin causes significant increases in the immunomodulatory cytokines transforming growth factor-β and prostaglandin E2[J].Transfusion,2006,46(8):1316-1322.
[10] BRINC D,LE-TIEN H,CROW A R,et al.Transfusion of antibody-opsonized red blood cells results in a shift in the immune response from the red blood cell to the antibody in a murine model[J].Transfusion,2010,50(9):2016-2025.
[11] CRUZ-LEAL Y,MARJORAM D,LAZARUS A H.Erythrocyte saturation with IgG is required for inducing antibody-mediated immune suppression and impacts both erythrocyte clearance and antigen-modulation mechanisms[J].J Immunol,2018,200(4):1295-1305.
[12] MAIER C L,MENER A,PATEL S R,et al.Antibody-mediated immune suppression by antigen modulation is antigen-specific[J].Blood Adv,2018,2(21):2986-3000.
[13] STOWELL S R,ARTHUR C M,GIRARD-PIERCE K R,et al.Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model[J].Haematologica,2015,100(10):e394-e397.
[14] LIU J C,SANTHANAKRISHNAN M,NATARAJAN P,et al.Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice[J].Blood,2016,128(26):3159-3168.
[15] WYLIE B J,D'ALTON M E.Fetomaternal hemorrhage[J].Obstet Gynecol,2010,115(5):1039-1051.
[16] ZHOU Y,ZHU Z Y,GAO Y,et al.Effects of maternal and fetal characteristics on cell-free fetal DNA fraction in maternal plasma[J].Reprod Sci,2015,22(11):1429-1435.
[17] ATTILAKOS G,MADDOCKS D G,DAVIES T,et al.Quantification of free fetal DNA in multiple pregnancies and relationship with chorionicity[J].Prenat Diagn,2011,31(10):967-972.
[18] HYLAND C A,MILLARD G M,O'BRIEN H,et al.Non-invasive fetal RHD genotyping for RhD negative women stratified into RHD gene deletion or variant groups:comparative accuracy using two blood collection tube types[J].Pathology,2017,49(7):757-764.
[19] PAPASAVVA T,MARTIN P,LEGLER T J,et al.Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma:a 5 year experience in Cyprus[J].BMC Res Notes,2016,9:198.
[20] SOOTHILL P,FINNING K,LATHAM T,et al.Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative:implementation in the NHS[J].BJOG:Int J Obstet Gynaecol,2015,122(12):1682-1686.
[21] BOWMAN JM.Thirty-five years of Rh prophylaxis. Transfusion 2003;(43):1661-1666.
[22] QURESHI H,MASSEY E,KIRWAN D,et al.BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn[J].Transfusion Med,2014,24(1):8-20.
[23] KIM Y A,MAKAR R S.Detection of fetomaternal hemorrhage[J].Am J Hematol,2012,87(4):417-423.
[24] JONES M L, WRAY J, WIGHT J, et al.A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant.[J]. Bjog An International Journal of Obstetrics & Gynaecology, 2004, 111(9):892-902.
[25] AVENT N D.Prenatal testing for hemolytic disease of the newborn and fetal neonatal alloimmune thrombocytopenia-current status[J].Expert Rev Hematol,2014,7(6):741-745. |
